Sensitive RP-HPLC method of rivastigmine for applicative quantification of nanostructured lipid carriers-Reference-Cited by-同舟云学术

Sensitive RP-HPLC method of rivastigmine for applicative quantification of nanostructured lipid carriers

Published:2023-05 Issue: Volume:188 Page:108341
ISSN:0026-265X
Container-title:Microchemical Journal
language:en
Short-container-title:Microchemical Journal

Author:

Hinge Nikita S.,Pandey Murali M.

Publisher

Elsevier BV

Subject

Spectroscopy,Analytical Chemistry

Reference27 articles.

1. F. Luis, G. Moncayo, EXELON (rivastigmine tartrate) Capsules, https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20823lbl.pdf.

2. Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer’s;Hinge;Appl. Mater. Today.,2022

3. Formulation and in-vivo pharmacokinetic consideration of intranasal microemulsion and mucoadhesive microemulsion of rivastigmine for brain targeting;Shah;Pharm. Res.,2018

4. Nose to brain delivery of rivastigmine by In Situ gelling cationic nanostructured lipid carriers: Enhanced brain distribution and pharmacodynamics;Wavikar;J. Pharm. Sci.,2017

5. Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease, Naunyn. Schmiedebergs;Rompicherla;Arch. Pharmacol.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applicability of QbD-assisted Analytical Method for Simultaneous Detection of Tetrahydrocurcumin and Folic Acid in Developed Nanostructured Lipid Carriers;Current Analytical Chemistry;2024-10

2. Determination of vitamin D3 in pharmaceutical products using salting-out assisted liquid–liquid extraction coupled with reversed phase liquid chromatography;Microchemical Journal;2023-10

3. Rivastigmine-DHA ion-pair complex improved loading in hybrid nanoparticles for better amyloid inhibition and nose-to-brain targeting in Alzheimer’s;European Journal of Pharmaceutics and Biopharmaceutics;2023-09